Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00253045 · ClinicalTrials.gov registry record · NA

Motivating HIV+ Women: Risk Reduction and ART Adherence

A NA study, sponsored by Emory University.

Completed
Registry status
NA
Development phase
207
Enrollment target

NCT00253045: Completed NA study, sponsored by Emory University.

NCT00253045 is a NA study that has completed, run by Emory University. The registered enrollment target is 207 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00253045, a NA study, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
207 participants
Enrollment target

Study Summary

The purpose of this study is to determine if a group motivational interviewing based intervention will increase adherence to antiretroviral medications and use of risk reduction behaviors.

Primary Outcome

Self report questionnaires, Electronic drug monitoring caps (MEMS)

Interventions

  • BEHAVIORAL Motivational groups

Trial Details

FieldValue
Enrollment Target 207 participants
Start Date 2004-08
Est. Completion 2008-01
Phase NA
Emory University

1,208 total trials

What the finished NCT00253045 record still lists

NCT00253045 is an interventional study that assigns participants to a tested intervention. The registered 207 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).

The record links to 0 conditions, and to 1 intervention - of which Motivational groups is the first listed.

NCT00253045 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00253045 about?

NCT00253045 is a clinical study titled "Motivating HIV+ Women: Risk Reduction and ART Adherence". The purpose of this study is to determine if a group motivational interviewing based intervention will increase adherence to antiretroviral medications and use of risk reduction behaviors.

What is the current status of trial NCT00253045?

This trial is currently completed. It is a NA study. The enrollment target is 207 participants. The study started on 2004-08. Estimated completion is 2008-01.

What interventions are being tested in trial NCT00253045?

The interventions under investigation include: Motivational groups (BEHAVIORAL).

Who is sponsoring clinical trial NCT00253045?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00253045's enrollment target sits among peer trials

207 499th of 2000 higher than 1,502 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04353778 · 207 participants · Phase 1

    Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV

  • NCT05875805 · 207 participants · NA

    A Telehealth Advance Care Planning Intervention

  • NCT06254950 · 207 participants · Phase 2

    A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis

  • NCT06904274 · 207 participants · Phase 3

    Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00253045, the US trial registry maintained by the National Library of Medicine. NCT00253045 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.